Home / Biopharma / CVS Health Corporation (NYSE:CVS) Declares Grand Opening of its New Orleans Lower Ninth Ward Location

CVS Health Corporation (NYSE:CVS) Declares Grand Opening of its New Orleans Lower Ninth Ward Location

CVS Health Corporation (NYSE:CVS) [Trend Analysis] regains street interests, as shares declined -1.48% on Monday and it traded at $99.46. The 52-week high of the share price is -11.43% and 52-week low of the share price is 23.71%.

CVS Pharmacy declared that grand opening of its New Orleans Lower Ninth Ward location, becoming the first major retailer to build in the neighborhood since Hurricane Katrina. CVS Pharmacy’s new store will serve as a building block in the revitalization of the Lower Nine Ward, one of the hardest hit communities affected by Hurricane Katrina.

Area Vice President of CVS Pharmacy, Roger Francis stated that CVS Pharmacy is extremely proud to now be a part of this community, giving residents convenient access to best in class pharmacy services and high quality health, beauty and wellness products. “More than 10 years ago, CVS Pharmacy was on the front lines of aiding in the relief and recovery efforts when Katrina struck, and now we are proud to be on the front lines helping to revitalize this community.”

Moving toward technical analysis, the current ratio, or the liquidity ratio of a company was calculated 1.20 as compared to its debt to equity ratio stands at 0.76. This is an important indicator as a higher ratio typically suggests that investors are investing more confidently as compared to companies in the same industry has lower ratios. When calculating in the EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at 16.80%. Investors looking further ahead will note that the Price to next year’s EPS is 12.73%.

To narrow down focus on firm’s analytic rating, CVS receives a wide range of reviews through technical indicators; experts eagerly produce EPS tends for quartile and annual, for current quarter trends were $1.31 and $1.55 for next quarter. On annual bases, it has $5.82 for FY 2016 Estimate Trends and $6.56 for FY 2017 Estimate Trends.

To neat down this understanding, 4 analysts rate it as ‘Holding’ security, at the same time as 19 suggests for ‘Buy’ as compare to 21 analyst suggested in 3 month ago. To lodge it average analyst gave price target to 114.26, whereas current price stands at 99.46.

As for as concerns shares volumes, in share capital CVS Health Corporation (NYSE:CVS) has 1090.11 million outstanding shares among them 1071.36 million shares have been floated in market exchange. The firm’s institutional ownership remained 85.20% while insider ownership included 0.10%.

The stock showed weekly upbeat performance of -4.06%, which maintained for the month at -1.74%. Likewise the positive performance for the quarter recorded as 2.47% and for the year was -2.62%, while the YTD performance remained at 2.61%.


About Devon Leftovich

Check Also

Hot Fact Under Analysts Views: AbbVie Inc. (NYSE:ABBV), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

AbbVie Inc. (NYSE:ABBV) [Trend Analysis] retains strong position in active trade, as shares scoring -0.21% …

Leave a Reply

Your email address will not be published. Required fields are marked *